No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
VSEC240816C90000
- 3.80
- -1.15-23.23%
15min DelayClose Jul 22 15:59 ET
3.80High3.80Low
3.80Open4.95Pre Close5 Volume5 Open Interest90.00Strike Price1.90KTurnover37.53%IV2.00%PremiumAug 16, 2024Expiry Date1.96Intrinsic Value100Multiplier24DDays to Expiry1.84Extrinsic Value100Contract SizeAmericanOptions Type0.6200Delta0.0423Gamma19.16Leverage Ratio-0.0772Theta0.0355Rho11.88Eff Leverage0.0913Vega
Intraday
- 5D
- Daily
News
RBC Capital Maintains VSE Corp(VSEC.US) With Buy Rating, Raises Target Price to $100
RBC Raises Price Target on VSE Corp. to $100 From $90, Keeps Outperform Rating
Express News | VSE Corp : RBC Raises Target Price to $100 From $90
Truist Financial Maintains VSE Corp(VSEC.US) With Buy Rating, Raises Target Price to $97
Analyst Expectations For VSE's Future
VSE Is Maintained at Buy by Truist Securities
Comments
VSE's start of profitability could signal fast earnings growth, justifying strong share price gains. The stock's recent improvement may hint at business momentum, suggesting now could be a great time to delve deeper into the company.
VSE (NASDAQ:VSEC) Investors Are up 9.6% in the Past Week, but Earnings Have Declined Over the Last Five Years 1
VSE's high P/E ratio is likely due to investors' expectations of strong future growth. The potential for earnings deterioration is not seen as significant enough to justify a lower P/E ratio, making a significant share price fall unlikely in the near future.
Upgrades
• $Great Ajax Corp(AJX.US$ : Compass Point Upgrades to Buy from Neutral - PT $16 (from $11)
• $AeroVironment(AVAV.US$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $100 (from $95)
• $Cardinal Health(CAH.US$ : Evercore ISI Upgrades to Outperform from In Line - PT $68 (from $55)
• $Cellectis(CLLS.US$ : Baird Upgrades to Outperform from Neutral - PT $10
• $Cooper Companies(COO.US$ : Citigroup Upgrades to Buy from Neutral
• $Endeavor Group(EDR.US$ : Goldman...
• $Great Ajax Corp(AJX.US$ : Compass Point Upgrades to Buy from Neutral - PT $16 (from $11)
• $AeroVironment(AVAV.US$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $100 (from $95)
• $Cardinal Health(CAH.US$ : Evercore ISI Upgrades to Outperform from In Line - PT $68 (from $55)
• $Cellectis(CLLS.US$ : Baird Upgrades to Outperform from Neutral - PT $10
• $Cooper Companies(COO.US$ : Citigroup Upgrades to Buy from Neutral
• $Endeavor Group(EDR.US$ : Goldman...
17
Read more